XML 40 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Investment in NEC TOKIN (Tables)
 3 Months Ended
Jun. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]  
Reconciliation between NEC TOKIN's net loss and KEMET's equity investment loss
Summarized financial information for TOKIN follows (amounts in thousands):
 
19 Day Period Ended April 19,
 
Quarters Ended June 30,
 
2017
 
2016
Sales
$
23,649

 
$
120,510

Gross profit
6,647

 
26,546

Net income (loss) (1)
247,786

 
2,350


(1)
The significant change between the periods was due to the gain from the Sale of EMD that occurred on April 14, 2017; see the discussion in Note 2, “Acquisitions” for more information.
A reconciliation between TOKIN’s net income (loss) and KEC’s equity investment income (loss) follows (amounts in thousands):
 
19 Day Period Ended April 19,
 
Quarters Ended June 30,
 
2017
 
2016
TOKIN net income (loss)
$
247,786

 
$
2,350

KEC’s economic interest %
34
%
 
34
%
Equity income (loss) from TOKIN before adjustments
84,247

 
799

 


 


Adjustments:


 


Amortization and depreciation
(113
)
 
(544
)
Removal of EMD memo accounts
(8,981
)
 
—

Inventory profit elimination
24

 
(32
)
Equity income (loss) from TOKIN
$
75,177

 
$
223

Acquired equity method investment income (loss)
$
240

 
$
—

Equity income (loss) from equity method investments
$
75,417

 
$
223
Schedule of Related Party Transactions
Summarized transactions between KEC and TOKIN are as follows (amounts in thousands):
 
19 Day Period Ended April 19,
 
Quarters Ended June 30,
 
2017
 
2016
KEC’s sales to TOKIN
$
727

 
$
3,147

TOKIN’s sales to KEMET
356

 
1,872